Fortis Healthcare Financial Statements

Fortis Healthcare Annually Results

Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar Mar-2021 Mar-2020 Mar-2018 Mar-2017
Growth matrix (%)        
Revenue growth (13) 1.57 (0.30) 8.93
Op profit growth (34) 123 (23) 73
EBIT growth (57) 63.10 (71) 282
Net profit growth (289) (106) (339) 2,189
Profitability ratios (%)        
OPM 10 13.20 5.99 7.72
EBIT margin 3.98 8 4.98 17.10
Net profit margin (2.70) 1.25 (22) 9.22
RoCE 1.82 4.48 2.82 10.30
RoNW (0.40) 0.27 (5.50) 2.20
RoA (0.30) 0.18 (3.10) 1.39
Per share ratios ()        
EPS (0.70) 1.21 -- 9.26
Dividend per share -- -- -- --
Cash EPS (5.30) (3.10) (24) 3.85
Book value per share 81.10 88.20 78.30 99.30
Valuation ratios        
P/E (269) 104 -- 19.40
P/CEPS (38) (41) (5.10) 46.70
P/B 2.45 1.43 1.58 1.81
EV/EBIDTA 35.80 16.40 17.50 10.90
Payout (%)        
Dividend payout -- -- -- --
Tax payout 1,817 (89) 73.70 (13)
Liquidity ratios        
Debtor days 38.40 36.60 37.70 36.60
Inventory days 7.02 5.71 5.13 4.85
Creditor days (62) (66) (61) (53)
Leverage ratios        
Interest coverage (1) (1.80) (0.90) (3.40)
Net debt / equity 0.18 0.20 0.43 0.32
Net debt / op. profit 2.75 2.18 6.38 4.73
Cost breakup ()        
Material costs (24) (21) (22) (22)
Employee costs (21) (20) (20) (20)
Other costs (45) (46) (52) (51)
Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar( In .Cr) Mar-2021 Mar-2020 Mar-2018 Mar-2017
Revenue 4,030 4,632 4,561 4,574
yoy growth (%) (13) 1.57 (0.30) 8.93
Raw materials (976) (964) (999) (998)
As % of sales 24.20 20.80 21.90 21.80
Employee costs (849) (916) (906) (905)
As % of sales 21.10 19.80 19.90 19.80
Other costs (1,801) (2,143) (2,383) (2,318)
As % of sales 44.70 46.30 52.20 50.70
Operating profit 404 610 273 353
OPM 10 13.20 5.99 7.72
Depreciation (291) (292) (239) (222)
Interest expense (166) (205) (258) (229)
Other income 46.60 52.60 193 652
Profit before tax (5.50) 165 (31) 553
Taxes (99) (148) (23) (72)
Tax rate 1,817 (89) 73.70 (13)
Minorities and other (54) (34) (75) (58)
Adj. profit (159) (16) (128) 423
Exceptional items 1.21 61.80 (881) (1.60)
Net profit (110) 57.90 (1,009) 422
yoy growth (%) (289) (106) (339) 2,189
NPM (2.70) 1.25 (22) 9.22
Switch to
Tabular Data
Graph
Y/e 31 Mar ( In .Cr) Mar-2021 Mar-2020 Mar-2018 Mar-2017
Profit before tax (5.50) 165 (31) 553
Depreciation (291) (292) (239) (222)
Tax paid (99) (148) (23) (72)
Working capital (795) (1,807) (886) 98.40
Other operating items -- -- -- --
Operating cashflow (1,191) (2,081) (1,178) 357
Capital expenditure 7,178 (196) (4,656) 725
Free cash flow 5,987 (2,277) (5,834) 1,082
Equity raised 8,696 9,040 7,293 7,409
Investments 87.80 (67) 544 60.50
Debt financing/disposal 1,488 3,930 (1,476) 2,672
Dividends paid -- -- -- --
Other items -- -- -- --
Net in cash 16,260 10,626 527 11,223
Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar ( In .Cr) Mar-2021 Mar-2020 Mar-2019 Mar-2018
Equity capital 755 755 755 519
Preference capital -- -- -- --
Reserves 5,365 5,906 5,846 3,543
Net worth 6,120 6,661 6,601 4,062
Minority interest
Debt 1,531 1,594 2,010 1,962
Deferred tax liabilities (net) 289 312 481 143
Total liabilities 8,537 9,111 9,604 7,422
Fixed assets 8,964 9,006 8,927 5,218
Intangible assets
Investments 186 175 270 1,732
Deferred tax asset (net) 370 393 465 295
Net working capital (1,400) (728) (914) (43)
Inventories 76.80 78.20 56.50 66.60
Inventory Days 6.95 6.16 -- 5.33
Sundry debtors 390 459 542 470
Debtor days 35.30 36.10 -- 37.60
Other current assets 751 971 835 620
Sundry creditors (579) (656) (785) (809)
Creditor days 52.40 51.70 -- 64.80
Other current liabilities (2,039) (1,580) (1,562) (390)
Cash 417 266 856 220
Total assets 8,537 9,111 9,604 7,422
Switch to
Consolidated
Standalone


Particulars ( Rupees In Crores.) Mar-2021 Mar-2020 Mar-2019 Mar-2018 Mar-2017
Gross Sales 4,030 4,632 4,469 4,561 4,574
Excise Duty -- -- -- -- --
Net Sales 4,030 4,632 4,469 4,561 4,574
Other Operating Income -- -- -- -- --
Other Income 95.30 127 457 193 652
Total Income 4,125 4,759 4,926 4,754 5,226
Total Expenditure ** 3,626 4,023 4,467 5,169 4,222
PBIDT 500 736 460 (415) 1,003
Interest 166 205 337 258 229
PBDT 334 531 123 (673) 774
Depreciation 291 292 233 239 222
Minority Interest Before NP -- -- -- -- --
Tax 99.50 148 114 22.70 72.40
Deferred Tax -- -- -- -- --
Reported Profit After Tax (56) 91.50 (224) (934) 479
Minority Interest After NP 53.60 33.60 75.20 74.80 57.60
Net Profit after Minority Interest (110) 57.90 (299) (1,009) 422
Extra-ordinary Items (1.60) 23.60 (109) (859) (1.40)
Adjusted Profit After Extra-ordinary item (108) 34.30 (190) (150) 423
EPS (Unit Curr.) (1.50) 0.77 (4.90) (19) 8.87
Book Value (Unit Curr.) -- -- -- -- --
Dividend (%) -- -- -- -- --
Equity 755 755 755 519 518
Public Shareholding (Number) -- -- -- -- --
Public Shareholding (%) -- -- -- -- --
Pledged/Encumbered - No. of Shares -- -- -- -- --
Pledged/Encumbered - % in Total Promoters Holding -- -- -- -- --
Pledged/Encumbered - % in Total Equity -- -- -- -- --
Non Encumbered - No. of Shares -- -- -- -- --
Non Encumbered - % in Total Promoters Holding -- -- -- -- --
Non Encumbered - % in Total Equity -- -- -- -- --
PBIDTM(%) 12.40 15.90 10.30 (9.10) 21.90
PBDTM(%) 8.28 11.50 2.75 (15) 16.90
PATM(%) (1.40) 1.98 (5) (20) 10.50
Open ZERO Brokerage Demat Account
Open ZERO Brokerage Demat Account

  • 0

    Delivery Brokerage for Lifetime

  • 20

    Per order for Intraday, F&O, Currency & Commodity